DOCSLIB.ORG

9780813810461.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
9780813810461.Pdf Nursing Care of the Hospitalized Older Patient Nursing Care of the Hospitalized Older Patient Edited by Terry Mahan Buttaro and Kate A. Barba A John Wiley & Sons, Inc., Publication This edition first published 2013 © 2013 by John Wiley & Sons, Inc Wiley-Blackwell is an imprint of John Wiley & Sons, formed by the merger of Wiley’s global Scientific, Technical and Medical business with Blackwell Publishing. Editorial Offices 2121 State Avenue, Ames, Iowa 50014-8300, USA The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 9600 Garsington Road, Oxford, OX4 2DQ, UK For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell. Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Blackwell Publishing, provided that the base fee is paid directly to the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license by CCC, a separate system of payments has been arranged. The fee codes for users of the Transactional Reporting Service are ISBN-13: 978-0-8138-1046-1/2013. Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required, the services of a competent professional should be sought. Library of Congress Cataloging-in-Publication Data Nursing care of the hospitalized older patient / edited by Terry Mahan Buttaro and Kate A. Barba. p. ; cm. Includes bibliographical references and index. ISBN 978-0-8138-1046-1 (pbk. : alk. paper) I. Buttaro, Terry Mahan. II. Barba, Kate A. [DNLM: 1. Geriatric Nursing–methods. 2. Aged. 3. Hospitalization. WY 152] 618.970231–dc23 2012004865 A catalogue record for this book is available from the British Library. Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books. Cover design by Buffy Clatt Set in 9/12.5pt Interstate by SPi Publisher Services, Pondicherry, India 1 2013 Dedication We dedicate this book to our husbands and children who have supported us throughout this endeavor. We always have and always will cherish the love you have shown us. Kate A. Barba Terry Mahan Buttaro Contents Contributors xiii Preface xix Acknowledgments xxi 1 Introduction 1 Terry Mahan Buttaro 2 Health Assessment 9 Kate A. Barba 3 Clinical Issues 22 Unit 1 Skin Disorders 22 Part 1 Overview 22 Terry Mahan Buttaro Part 2 Burns 24 Terry Mahan Buttaro Part 3 Cellulitis 27 Terry Mahan Buttaro Part 4 Contact Dermatitis 31 Terry Mahan Buttaro Part 5 Herpes Zoster 33 Terry Mahan Buttaro Part 6 Purpura 37 Terry Mahan Buttaro Part 7 Pruritus 41 Terry Mahan Buttaro Part 8 Acne Rosacea 44 Terry Mahan Buttaro Part 9 Seborrheic Dermatitis 46 Terry Mahan Buttaro Part 10 Thrush 50 Terry Mahan Buttaro vii viii Contents Part 11 Tinea 52 Terry Mahan Buttaro Part 12 Pressure Ulcers 56 Linda Olson Part 13 Lower Extremity Ulcers 64 Linda Olson Part 14 Skin Tears 74 Linda Olson Unit 2 Cardiovascular Disorders 79 Part 1 Acute Coronary Syndrome 79 Sharon Zisk Part 2 Atrial Fibrillation 86 Theresa E. Evans Part 3 Venous Thromboembolism 92 Eva Beliveau Part 4 Heart Failure 99 Theresa E. Evans Part 5 Hypertension 105 Chelby Cierpial and Susan Stengrevics Part 6 Peripheral Vascular Disease 112 Ashley Moore Gibbs Part 7 Heart Valve Disease 117 Theresa E. Evans Unit 3 Respiratory Disorders 124 Part 1 Asthma 124 Marian Jeffries and Rosemarie Marks Part 2 Chronic Obstructive Pulmonary Disease (COPD) 128 Marian Jeffries and Rosemarie Marks Part 3 Influenza 134 Marian Jeffries and Rosemarie Marks Part 4 Pneumonia 138 Marian Jeffries and Rosemarie Marks Unit 4 Gastrointestinal Disorders 148 Part 1 Appendicitis 148 Patricia Fitzgerald Part 2 Diverticular Disease 152 Patricia Fitzgerald Contents ix Part 3 Ischemic Bowel 158 Patricia Fitzgerald Part 4 Pancreatitis 162 Patricia Fitzgerald Part 5 Constipation 167 Patricia Fitzgerald Part 6 Diarrhea 173 Patricia Fitzgerald Part 7 Gastroesophageal Reflux Disease 178 Patricia Fitzgerald Unit 5 Genitourinary Disorders 183 Part 1 Acute Kidney Injury 183 Carol A. Tyksienski Part 2 Chronic Kidney Disease 191 Carol A. Tyksienski Part 3 Urinary Tract Infections 197 Terry Mahan Buttaro Unit 6 Neurologic Disorders 202 Part 1 Dementia 202 Constance Cruz, Sara A. Fisher, Mary Lussier-Cushing and Jennifer Repper-DeLisi Part 2 Delirium in the Older Hospitalized Adult 209 Mary Lussier-Cushing, Jennifer Repper-DeLisi, Sara A. Fisher and Constance Cruz Part 3 Ischemic Stroke 221 Marion Phipps Part 4 Dizziness 230 Jean B. Fahey Part 5 Normal Pressure Hydrocephalus 236 Jean B. Fahey Part 6 Parkinson’s Disease 241 Marion Phipps Part 7 Seizures 249 Susan R. Gavaghan Unit 7 Endocrine 255 Part 1 Diabetes 255 Susan L. Wood x Contents Part 2 Hypo/Hyperthyroidism 269 Susan L. Wood Part 3 Hyperparathyroidism/Hypoparathyroidism 275 Susan L. Wood Part 4 Syndrome of Inappropriate Antidiuretic Hormone Secretion 283 Susan L. Wood Unit 8 Musculoskeletal 288 Part 1 Septic Arthritis 288 Susan Bardzik Part 2 Gout 292 Sharon R. Smart Part 3 Joint Replacement 296 Nichole Spencer Part 4 Osteomyelitis 303 Lesley Caracci Part 5 Metabolic Bone Disease: Osteoporosis and Paget’s Disease 308 Nichole Spencer Unit 9 Hematology/Oncology 316 Part 1 The Oncology Patient 316 Kristina N. Wickman Unit 10 Infectious Disease 324 Part 1 HIV/AIDS 324 Caroline Sturm-Reganato Part 2 Sepsis and ARDS 337 Vince M. Vacca, Jr. Part 3 Tuberculosis 343 Melissa Donovan Unit 11 Multisystem Disorders 351 Part 1 Fever 351 Monica G. Staples Part 2 Polymyalgia Rheumatica 359 Monica G. Staples Part 3 Rheumatoid Arthritis 364 Monica G. Staples Part 4 Systemic Lupus Erythematosus 369 Kate Roche Contents xi Part 5 Temporal Arteritis 376 Kate Roche Part 6 Vasculitis 379 Kate Roche Unit 12 The Surgical Patient 386 Part 1 The Surgical Patient 386 Deanne C. Munroe Unit 13 Fluid and Electrolytes 403 Part 1 Dehydration and other Hypovolemic Fluid Disorders 403 Terry Mahan Buttaro Part 2 Hypercalcemia and Hypocalcemia 408 Nancy A. Kelly Part 3 Hyperkalemia and Hypokalemia 416 Grace A. Good Part 4 Hyponatremia and Hypernatremia 423 Grace A. Good Part 5 Hypomagnesemia and hypermagnesemia 432 Nancy A. Kelly Unit 14 Psychological Issues 440 Part 1 Anxiety Disorders 440 Constance Cruz, Sara A. Fisher, Mary Lussier-Cushing and Jennifer Repper-DeLisi Part 2 Depression 445 Jennifer Repper-DeLisi, Constance Cruz, Sara A. Fisher and Mary Lussier-Cushing 4 Special Considerations 454 Part 1 Nosocomial Infections 454 Hallie S. Greenberg Part 2 Elder Abuse and Neglect 461 Margaretta Byrne Part 3 Advance Directives 469 Anita M. Coppola-Ash Part 4 Nutrition and Older Adults 474 Deborah A. D’Avolio Part 5 Fall Prevention 480 Deborah A. D’Avolio xii Contents Part 6 Pain and Older Adults 488 Deborah A. D’Avolio Part 7 Palliative Care 494 Jennifer R. Howard Part 8 Medications and Older Adults 501 Deborah A. D’Avolio Part 9 Sleep Disorders 506 Donna M. Glynn Part 10 Urinary Incontinence 511 Mary L. McDonough Part 11 Discharge Planning and Teaching 518 Arlene J. Lowenstein Part 12 SBAR Communication 525 Eva Beliveau Glossary 531 Selected Websites for Geriatric Information 536 Index 537 Contributors Editors Terry Mahan Buttaro, PhD, ANP-BC, GNP-BC, FAANP, DPNAP Assistant Clinical Professor Simmons College Boston, Massachusetts Lecturer University of Massachusetts Boston Boston, Massachusetts Nurse Practitioner Coastal Medical Associates Salisbury, Massachusetts Kate A. Barba, RN, MS, GNP-BC Clinical Nurse Specialist Massachusetts General Hospital Boston, Massachusetts Contributors Susan Bardzik, RN-BC, MSN Massachusetts General Hospital Boston, Massachusetts Eva Beliveau, RN, MSN Associate Professor Department of Nursing Northern Essex Community College Lawrence, Massachusetts Margaretta Byrne, MPH, MS, FNP-BC Master’s in Nursing Student Simmons College Boston, Massachusetts Lesley Caracci, RN, MSN, ACNS-BC Massachusetts General Hospital Boston, Massachusetts xiii xiv Contributors Chelby Cierpial, RN, MSN, ACNS, BC Clinical Nurse Specialist/Ellison 11 Cardiac Interventional Unit Massachusetts General Hospital Boston, Massachusetts Anita M. Coppola-Ash, RN, BSN, MSN, ANP-BC, LCSW, MSW Anna Jacques Hospital Newburyport, Massachusetts Constance Cruz, RN, MSN, PMHCNS Psychiatric Clinical Nurse Specialist Inpatient Psychiatric Unit Massachusetts General Hospital Boston, Massachusetts Deborah A. D’Avolio PhD, BC-ACNP, ANP Associate Professor School of Nursing Northeastern University Boston, Massachusetts Melissa Donovan, MSN, RN Massachusetts General Hospital Boston, Massachusetts Theresa E. Evans, MS, ANP-BC Clinical Nurse Specialist Massachusetts General Hospital Boston, Massachusetts Jean B. Fahey, MSN, RN, ACNS-BC, CCRN, CNRN, CWS Neuroscience Clinical Nurse Specialist Massachusetts General Hospital Boston, Massachusetts Sara A. Fisher, MSN, RN, PMHCNS-BC Psychiatric Clinical
Load more

Recommended publications
  • Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia
    Article Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia Jason C. George ,1 Waleed Zafar,2 Ion Dan Bucaloiu,1 and Alex R. Chang 1,2 Abstract Background and objectives Rapid correction of severe hyponatremia can result in serious neurologic complications, including osmotic demyelination. Few data exist on incidence and risk factors of rapid 1Department of correction or osmotic demyelination. Nephrology, Geisinger Medical Center, Design, setting, participants, & measurements In a retrospective cohort of 1490 patients admitted with serum Danville, , Pennsylvania; and sodium 120 mEq/L to seven hospitals in the Geisinger Health System from 2001 to 2017, we examined the 2 incidence and risk factors of rapid correction and osmotic demyelination. Rapid correction was defined as serum Kidney Health . Research Institute, sodium increase of 8 mEq/L at 24 hours. Osmotic demyelination was determined by manual chart review of Geisinger, Danville, all available brain magnetic resonance imaging reports. Pennsylvania Results Mean age was 66 years old (SD=15), 55% were women, and 67% had prior hyponatremia (last outpatient Correspondence: sodium ,135 mEq/L). Median change in serum sodium at 24 hours was 6.8 mEq/L (interquartile range, 3.4–10.2), Dr. Alexander R. Chang, and 606 patients (41%) had rapid correction at 24 hours. Younger age, being a woman, schizophrenia, lower Geisinger Medical , Center, 100 North Charlson comorbidity index, lower presentation serum sodium, and urine sodium 30 mEq/L were associated Academy Avenue, with greater risk of rapid correction. Prior hyponatremia, outpatient aldosterone antagonist use, and treatment at an Danville, PA 17822. academic center were associated with lower risk of rapid correction.
    [Show full text]
  • Diagnosis and Management of Hyponatremia Melinda Johnson, MD, FHM, FACP, FPHM Associate Professor, Internal Medicine University of Iowa Hospitals and Clinics
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Iowa Research Online UPDATED Diagnosis and Management of Hyponatremia Melinda Johnson, MD, FHM, FACP, FPHM Associate Professor, Internal Medicine University of Iowa Hospitals and Clinics Hyponatremia Low serum Normal or high osmolality serum <280 mOsm/kg osmolality Pseudo- Euvolemic Hypervolemic Redistributive Hypovolemic hyponatremia Una <20 mEq/L Una >20 mEq/L Una >20, Uosm Una >20, Uosm Una<20 mEq/L Una>20 mEq/L Uosm >300 Uosm <100 Hyperlipidemia Hyperglycemia <100 mOsm/kg >300 mOsm/kg mOsm/kg mOsm/kg Mannitol, Drug effect maltose, Advanced renal Hyper- Dehydration (thiazides, ACE- Beer potomania SIADH CHF sucrose, glycine, failure proteinemia I) or sorbitol administration Salt-wasting Psychogenic Diarrhea Postoperative Liver disease Biliary Azotemia nephropathies polydipsia Mineralocorti- Hypo- Nephrotic Alcohol Vomiting coid deficiency thyroidism syndrome intoxication Drug effect Cerebral (thiazides, ACE- sodium-wasting I) Adrenocorticotr opin deficiency Hyponatremia Serum sodium concentration <135 mEq/L Severe hyponatremia <120 mEq/L Disorder of water, not salt Occurs in ~15% of all hospital inpatients Increased morbidity and mortality Symptoms depend on rate of fall 1 Total Body Water Intracellular Interstitial Intravascular •Water load, causing decreased serum Sosm osmolality •Leading to suppressed ADH ADH (vasopressin) •Leading to water excretion in dilute Uosm urine (decreased Uosm) Impaired Renal Water Excretion 1. Inability to
    [Show full text]
  • 2018 National Conference Poster Abstracts
    2018 Poster Abstracts August 2-4, 2018 – National Conference of Family Medicine Residents and Medical Students – Kansas City, MO The purpose of the National Conference poster competition is to stimulate research by medical students and family medicine residents, to provide a venue to share innovative and effective educational programs, to showcase unique community projects, and to encourage networking among medical students and residents with similar interests. This year's authors offer valuable information in the categories of clinical inquiry, community projects, educational programs, and research. Poster Presentations Pelvic Inflammatory Disease: Challenges in Diagnosis (Clinical Inquiry) Catherine Peony Khoo, MD University of California, Los Angeles Pelvic inflammatory disease (PID) is a common infection with an estimated lifetime prevalence of 4.4% in reproductive-aged women in the United States. However, given its nonspecific signs and symptoms along with a lack of readily available specific diagnostic testing, PID remains a clinical diagnosis that may pose diagnostic challenges resulting in serious morbidity and mortality. The case presented is that of a perimenopausal woman presenting with fever and lower abdominal pain who was misdiagnosed on multiple occasions in both ambulatory and hospital settings until she was finally found to have sepsis secondary to PID complicated by tuboovarian abscess. Her case highlights multiple important points in diagnosis of PID, pathogenic organisms, and risk factors implicated in PID in postmenopausal women, treatment of PID, and cognitive error contributing to preventable misdiagnosis. How Insufficient Asthma Control Can Break Your Heart (Clinical Inquiry) Louai Naddaf and Sujan Thapaliya, MD Saba University School of Medicine Background: 61-year-old female presented with severe shortness of breath, wheezing, orthopnea, a productive cough, and lower limb edema upon waking up at night.
    [Show full text]
  • European Life Science Ceo Forum
    WELCOME SPONSORS SPEAKERS PRESENTING COMPANIES 3rd Annual EUROPEAN LIFE SCIENCE CEO FORUM for PARTNERING & INVESTING AWARDS ORGANISATIONS PARTNERING 11-12 February 2010 ConventionPoint, Zurich, Switzerland Conference Guide REGIONAL PARTNERS ORGANISERS EUROPEAN LIFE SCIENCE CEO FORUM www.sachsforum.com WELCOME SPONSORS next Welcome Sachs Associates are delighted to welcome you to the: SPEAKERS PRESENTING COMPANIES 3rd Annual European Life Science CEO Forum for Partnering & Investing 11-12 February 2010 ConventionPoint, Zurich, Switzerland Sachs Associates are delighted to welcome you to the 3rd Annual European Life Science CEO Forum for Partnering & Investing. Following its success from previous years, the forum once again provides access to an exciting cross-section of venture-funded and small-cap companies with leading investors and pharmas. This exclusive and transactional event complements our Annual Biotech in Europe Investor Forum, held later in the year, but with added focus on Partnering & the pharmaceutical industry, feature presentations from Big Pharma representatives demonstrating their AWARDS ORGANISATIONS PARTNERING current and future partnering strategies through thought-provoking case studies. This year’s programme features a series of panels and presentations from leading investment, pharmaceutical and biotech companies, highlighting the current issues surrounding the evolving M&A market, Vaccines, Medtech Investment and includes special keynote speeches, providing an expert outlook on Europe’s Biotech industry. In addition, the event holds more than 50 company presentations from an exciting and diverse range of publicly listed and private life science companies, looking to raise fi nance and/or fi nd partners. This year’s DyoDelta Life Science Innovation Awards takes place in the evening of the 11th February and the awards recognise exceptional performance in key categories of partnering and fi nancing within the industry.
    [Show full text]
  • Beer Potomania: a Challenging Case of Hyponatremia Hind Rafei George Washington University
    Himmelfarb Health Sciences Library, The George Washington University Health Sciences Research Commons Medicine Faculty Publications Medicine 8-2016 Beer Potomania: A Challenging Case of Hyponatremia Hind Rafei George Washington University Raza Yunus George Washington University Parvinder S. Khurana George Washington University Follow this and additional works at: http://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs Part of the Carbohydrates Commons, and the Substance Abuse and Addiction Commons APA Citation Rafei, H., Yunus, R., & Khurana, P. S. (2016). Beer Potomania: A Challenging Case of Hyponatremia. Journal of Endocrinology and Metabolism, 6 (4). http://dx.doi.org/10.14740/jem350e This Journal Article is brought to you for free and open access by the Medicine at Health Sciences Research Commons. It has been accepted for inclusion in Medicine Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please contact [email protected]. Elmer ress Case Report J Endocrinol Metab. 2016;6(4):123-126 Beer Potomania: A Challenging Case of Hyponatremia Hind Rafeia, Raza Yunusa, Parvinder Khuranaa, b Abstract been referred to as beer potomania [1]. The term beer potoma- nia is used to describe a patient who presents with hyponatrem- Beer potomania is a syndrome of hyponatremia associated with exces- ia in conjunction with low daily solute intake and excessive sive beer drinking. Little or no salt content of beer results in marked beer drinking. Little or no salt content of beer, and suppression reduction in the solute load to the kidney. This leads to impaired water of protein breakdown by the carbohydrate and alcohol content clearance and dilutional hyponatremia.
    [Show full text]
  • Rudys List of Archaic Medical Terms.Xlsm
    Rudy's List of Archaic Medical Terms A Glossary of Archaic Medical Terms, Diseases and Causes of Death. The Genealogist's Resource for Interpreting Causes of Death. Section 1 English Archaic Medical Terms Section 2 German / English Glossary Section 3 International / English Glossary www.antiquusmorbus.com Copying and printing is allowed for personal use only. Distribution or publishing of any kind is strictly prohibited. © 2005-2008 Antiquus Morbus, All Rights Reserved. This page left intentionally blank Rudy's List of Archaic Medical Terms A Glossary of Archaic Medical Terms, Diseases and Causes of Death. The Genealogist's Resource for Interpreting Causes of Death. Section 1 English Archaic Medical Terms Section 2 German / English Glossary Section 3 International / English Glossary www.antiquusmorbus.com Copying and printing is allowed for personal use only. Distribution or publishing of any kind is strictly prohibited. © 2005-2008 Antiquus Morbus, All Rights Reserved. This page left intentionally blank Table of Contents Section 1 Section 2 Section 3 EnglishGerman International Part 2 PAGE Part 4 PAGE Part 6 PAGE English A 5 German A 123 Croatian 153 English B 10 German B 124 Czech 154 English C 14 German C 127 Danish 155 English D 25 German D 127 Dutch 157 English E 29 German E 128 Finnish 159 English F 32 German F 129 French 161 English G 34 German G 130 Greek 166 English H 38 German H 131 Hungarian 167 English I 41 German I 133 Icelandic 169 English J 44 German J 133 Irish 170 English K 45 German K 133 Italian 170 English L 46 German
    [Show full text]
  • Focal Neurological Deficit Secondary to Severe Hyponatraemia Mimicking Stroke
    European Journal of Case Reports in Internal Medicine Focal Neurological Deficit Secondary to Severe Hyponatraemia Mimicking Stroke Ahmad Nawid Latifi1, Vanitha Gopal1, Sina Raissi2 1Department of Internal Medicine, Saint Mary’s Hospital, Waterbury, CT, USA 2Department of Nephrology, Saint Mary’s Hospital, Waterbury, CT, USA Doi: 10.12890/2019_001244 - European Journal of Case Reports in Internal Medicine - © EFIM 2019 Received: 29/07/2019 Accepted: 17/09/2019 Published: 11/10/2019 How to cite this article: Latifi AN, Gopal V, Raissi S. Focal neurological deficit secondary to severe hyponatraemia mimicking stroke.EJCRIM 2019;6: doi:10.12890/2019_001244. Conflicts of Interests: The Authors declare that there are no competing interest This article is licensed under a Commons Attribution Non-Commercial 4.0 License ABSTRACT Hyponatraemia is a common electrolyte abnormality seen by internists. Clinical features of hyponatraemia are primarily related to CNS dysfunction, and depend on the severity and acuity of changes in serum sodium concentration. Neurological manifestations of hyponatraemia range from nausea and malaise, with a mild reduction in the serum sodium, to lethargy, decreased level of consciousness, headache, seizures and coma in extreme cases. Focal neurological deficits are very rare in the setting of hyponatraemia. Here, we describe a patient with acute severe symptomatic hyponatraemia presenting with focal neurological deficits that resolved after correction of acute hyponatraemia. LEARNING POINTS • A rare presentation of hyponatraemia is described. • Neuroimaging should be performed in patients with focal neurological deficits and hyponatraemia in order to rule out other serious neurological diseases. • Correction of severe hyponatraemia can result in resolution of focal neurological deficits.
    [Show full text]
  • Acid-Base and Electrolyte Disorders in Alcohol Abuse
    Electrolyte Disorders in Chronic Alcohol Use Disorder: A Case Based Approach Biff F. Palmer, M.D. Professor of Internal Medicine University of Texas Southwestern Medical Center, Dallas Texas Case • A 52-year-old homeless man presents to the emergency room complaining of weakness. He typically drinks one pint of whisky daily. He noted the onset of epigastric pain 3 days ago but continued to drink until 1 day prior to presentation, when he developed the onset of nausea and persistent vomiting. He reports having had no food intake over the last 24 hours. • PE: BP 138/90 mm Hg supine, 110/74 mm Hg standing, pulse 105 beats/minute. There is tenderness to palpation in the epigastrium but no rebound tenderness. Laboratory Data Creatinine 1.2 mg/dl Arterial blood gas: BUN 22 mg/dl – pH 7.47 Serum electrolytes –PCO2 28 (mEq/l): – Na + 142 –K+ 3.8 – Cl - 92 - – HCO 3 22 Glucose 110 mg/dl Which of the following best describes the acid- base disturbance in this patient? 1. Chronic respiratory alkalosis 2. Anion gap metabolic acidosis 3. Respiratory alkalosis and metabolic acidosis 4. Anion gap metabolic acidosis, respiratory alkalosis, and metabolic alkalosis Case • Arterial pH = 7.47 142 92 22 • pCO 2 = 28 mmHg 3.8 22 1.2 Anion gap 28 • Anion gap metabolic acidosis • Metabolic alkalosis • Respiratory alkalosis Case • A man with chronic alcohol use disorder is found lying semiconscious at the bottom of a stairwell with a broken arm by his landlady, who called an ambulance to take him to the ED. + + - - • Labs (mEq/l): Na 137, K 3.6, Cl 90, HCO 3 15 (anion gap 32), ethanol level 150 mg/dl, glucose 38 mg/dl Which of the following best accounts for the hypoglycemia and increased anion gap? 1.
    [Show full text]
  • Society of General Internal Medicine
    Society of General Internal Medicine 24th Annual Meeting San Diego, California May 2±5, 2001 ABSTRACTS SEVERE HYPERNATREMIA DUE TO A HIGH CALORIE MEAL SUPPLEMENT. D. 1 1 CLINICAL VIGNETTES Addamo ; Mount Sinai School of Medicine, New York, NY LEARNING OBJECTIVES: 1) Raise index of suspicion for severe metabolic derangement in elderly patients. 2) Recognize clinical signs of hypernatremia. 3) Recognize limitations of using concentrated supplements as meal replacement. CASE INFORMATION: A 79 year old woman with advanced Alzheimer's disease was brought SUCCESSFUL TREATMENT OF RECURRENT LEUKOCYTOCLASTIC VASCULITIS to the E.D. due to a 4-week progressive decline in her overall level of function. She had been WITH CELOCOXIB IN A CYSTIC FIBROSIS PATIENT. C. Vergara1,R.Knauft2; hospitalized 8 weeks prior for an aspiration pneumonia. Her daily fluid intake since that time 1University of Connecticut Health Center, Farmington, CT; 2Hartford Hospital, Hartford, consisted of six 8oz cans of a ``balanced nutrition shake'', along with some soup. 4 days prior she CT was given antibiotics by her primary physician. She showed no improvement and developed diarrhea. Physical exam revealed an obtunded woman. Her pulse was 120bpm and rectal LEARNING OBJECTIVES: Recognize the occurence of leucocytoclastic vasculitis in cystic temperature was 38.9 Celsius. She was normotensive. She had dry oral mucosa and skin tenting. fibrosis patients. Recognize arthalgias and tendonitis associated with such conditions. Treat Her neurological exam was nonfocal. Lab studies were significant for sodium of 185mEq/L, such conditions with Celocoxib - a COX 2 inhibitor nonsteroidal anti-inflammatory agent. chloride of 148mEq/L, BUN of 124mg/dL and a creatinine of 3.0mg/dL.
    [Show full text]
  • Listening, Responding and Working Toward a Healthier Future
    Listening, responding and working toward a healthier future OUR COMMITMENT, PERFORMANCE, IMPACT AND ASPIRATIONS Corporate Responsibility 2006–2007 Report FOLD HINGE SPINE HINGE Our Medicines and Vaccines PRODUCT NAME THERAPEUTIC AREA ATHEROSCLEROSIS & CARDIOVASCULAR Cozaar® (losartan potassium) High blood pressure Hyzaar® (losartan potassium and hydrochlorothiazide) High blood pressure Sustainable business success depends on making quality products that Vytorin® (ezetimibe/simvastatin)* High cholesterol Zetia® (ezetimibe)* High cholesterol DIABETES & OBESITY people value, on sound fi nancial stewardship and on responsible governance Janumet® (sitagliptin/metformin HCI) Type 2 diabetes Januvia® (sitagliptin phosphate) Type 2 diabetes INFECTIOUS DISEASES that ensures we meet customers’ needs ethically and transparently. Atripla® (efavirenz 600mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)† HIV infection Cancidas® (caspofungin acetate) Certain fungal infections Ut wisi enim ad minim veniam, quis Duis autem vel eum iriure dolor in Duis autem vel eum iriure dolor in Ut wisi enim ad minim veniam, quis Duis autem vel eum iriure dolor in Duis autem vel eum iriure dolor in consequat,Crixivan vel® (indinavir illum sulfate) dolore eu feugiat ullamcorper suscipit lobortis nisl utHIV infectionullamcorper suscipit lobortis nisl ut nostrud exerci tation hendrerit in vulputate velit esse molestie hendrerit in vulputate velit esse molestie nostrud exerci tation hendrerit in vulputate velit esse molestie hendrerit in vulputate velit esse molestie nulla Invanzfacilisis.® (ertapenem sodium) aliquip ex ea commodo consequat.Certain bacterialaliquip infections ex ea commodo consequat. consequat, vel illum dolore eu feugiat consequat, vel illum dolore eu feugiat consequat, vel illum dolore eu feugiat consequat, vel illum dolore eu feugiat Isentress® (raltegravir) HIV infection Duis autem vel eum iriure dolor in nulla facilisis.
    [Show full text]
  • Hyponatremia Hyponatremia
    Guide to Clinical Validation, Documentation and Coding Hyponatremia Hyponatremia E87.1 Hypo-osmolality and hyponatremia CC Diagnosis: hyponatremia/hypo-osmolality/hypotonic dehydration Discussion Hyponatremia is decreased sodium level in the blood. Serum osmolarity is low in true hyposmolar hyponatremia. It occurs from a loss of total body sodium or dilution of serum sodium due to excess water in plasma. The latter mechanism is the most common cause of hyponatremia. The lowered sodium level allows excess water to enter cells, causing them to swell. Infancy, advanced age, debilitation, long-term care residency, impaired mental status, brain injury status, and hospitalization are high-risk factors for developing hyponatremia. Identification of the underlying cause is important in the management. The efficacy of treatment is influenced by the onset; acute hyponatremia has a rapid drop of sodium level < 48 hours. The results can cause critical physiologic effects. Acute hyponatremia that is severe should be corrected slowly, with increase in serum Na concentration not exceeding 10 mEq/L over the first 24 hours; chronic hyponatremia has a gradual drop of sodium level over several days (> 48 hours) or weeks. The results are usually moderate; can be asymptomatic. When it is symptomatic, it should be corrected slowly due to the risk of cerebral edema during treatment. Treatment variables depend on whether the hyponatremia is acute or chronic, the classification (fluid balance), and severity of the symptoms, the patients’ weight (use in formulae) and the underlying cause. Documentation Tip Code assignment cannot be based on ancillary test results, therapies, or clinical criteria alone. A diagnosis and its clinical significance must be supported by physician or other qualified healthcare professional documentation.
    [Show full text]
  • Metabolic Abnormalities in Alcoholic Patients: Focus on Acid Base And
    lism and D ho ru o g lc D A e p f e o Journal of n l Moses Elisaf and Rigas Kalaitzidis, J Alcohol Drug Depend 2015, 3:1 d a e n r n c u e o DOI: 10.4172/2329-6488.1000185 J ISSN: 2329-6488 Alcoholism & Drug Dependence ReviewResearch Article Article OpenOpen Access Access Metabolic Abnormalities in Alcoholic Patients: Focus on Acid Base and Electrolyte Disorders Moses Elisaf MD1,2* and Rigas Kalaitzidis MD1 1Department of Nephrology, University Hospital of Ioannina, Ioannina, Greece 2Department of Internal Medicine, Medical School, University of Ioannina, 451 10, Ioannina, Greece Abstract Alcoholic patients commonly develop a variety of acid-base and electrolyte disturbances. The aim of this review is to describe the most commonly encountered abnormalities and their significant role in the patients’ morbidity and mortality. Physicians should be aware of these clinically important disturbances caused by alcohol abuse and their underlying pathophysiological mechanisms involved for their appropriate management. Alcoholic Keto Acidosis (AKA) is a medical emergency is more common than previously thought and is characterized by an increased anion gap metabolic acidosis. However, in AKA mixed acid-base disorders are commonly observed. Alcoholic patients also exhibit severe electrolyte derangements. Multifactorial origin hypomagnesaemia is the most common electrolyte abnormality observed. Hypocalcaemia is also a frequent electrolyte disturbance and is commonly associated with hypomagnesaemia. Hypokalemia is occasionally encountered in these patients, while multifactorial origin hypophosphatemia is the second common electrolyte abnormality found. Hyponatremia is also a common electrolyte derangement and may occur subsequent to several mechanisms mediated by alcohol toxicity.
    [Show full text]